CAMARDA, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 3.015
EU - Europa 649
AS - Asia 532
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 4.203
Nazione #
US - Stati Uniti d'America 3.001
CN - Cina 271
UA - Ucraina 167
DE - Germania 143
TR - Turchia 116
SG - Singapore 109
GB - Regno Unito 104
IT - Italia 99
FI - Finlandia 55
SE - Svezia 46
VN - Vietnam 27
CA - Canada 14
BE - Belgio 9
FR - Francia 9
NL - Olanda 6
RU - Federazione Russa 4
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IR - Iran 2
PL - Polonia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
EC - Ecuador 1
HK - Hong Kong 1
IE - Irlanda 1
LU - Lussemburgo 1
NP - Nepal 1
ZA - Sudafrica 1
Totale 4.203
Città #
Fairfield 475
Woodbridge 431
Houston 245
Jacksonville 188
Ashburn 186
Seattle 175
Chandler 173
Cambridge 161
Ann Arbor 139
Wilmington 136
Singapore 88
Nanjing 64
Izmir 62
Beijing 51
San Diego 47
New York 44
Princeton 40
Milan 39
Boardman 33
Munich 31
Shanghai 31
Dong Ket 26
Dearborn 22
Bremen 20
Ferrara 20
Helsinki 20
Addison 16
Hebei 16
Mcallen 16
Shenyang 16
Nanchang 13
Auburn Hills 12
Montréal 12
Changsha 10
Brussels 9
Norwalk 9
Philadelphia 9
Santa Clara 9
Los Angeles 8
Jiaxing 7
Jinan 7
Ningbo 7
Tianjin 7
Mountain View 6
Falls Church 5
Indiana 5
London 5
Tappahannock 5
Amsterdam 4
Padova 4
Redwood City 4
San Mateo 4
Guangzhou 3
Kunming 3
Orange 3
Redmond 3
Taizhou 3
Verona 3
Zhengzhou 3
Acton 2
Augusta 2
Aurora 2
Bologna 2
Des Moines 2
Hefei 2
Hounslow 2
Jakarta 2
Lanzhou 2
Lodz 2
Messina 2
Monmouth Junction 2
Prescot 2
San Francisco 2
Scorzè 2
Toronto 2
Wandsworth 2
Washington 2
Ardabil 1
Boston 1
Brno 1
Buffalo 1
Chicago 1
Chiswick 1
Collecorvino 1
Colleferro 1
Dublin 1
Düsseldorf 1
Fuzhou 1
Hanoi 1
Hendon 1
Islington 1
Kilburn 1
La Canada Flintridge 1
Las Vegas 1
Leawood 1
Leicester 1
Liberty Lake 1
Loja 1
Luxembourg 1
Mansfield 1
Totale 3.252
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 241
null 205
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 146
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 140
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 134
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 133
A new ligand for the urotensin II receptor 128
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 126
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 119
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 117
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 116
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 115
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 112
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 112
Structure-activity study at positions 3 and 4 of human neuropeptide S. 112
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 110
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 108
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 108
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 107
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 107
Pharmacological characterisation of novel kinin B2 receptor ligands 106
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 105
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 105
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 104
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 99
Structure-activity relationship study on human urotensin II 98
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 97
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 97
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 96
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. 94
null 94
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 91
null 87
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 84
null 78
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 68
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 66
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 30
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 26
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 17
Totale 4.238
Categoria #
all - tutte 17.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 583
Totale 17.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020815 0 0 0 152 84 123 98 104 86 94 51 23
2020/2021580 48 62 26 91 23 50 31 62 13 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024266 21 32 15 8 8 59 11 21 3 4 16 68
2024/2025167 35 27 105 0 0 0 0 0 0 0 0 0
Totale 4.238